Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer’s disease: comparison of a semiquantitative and a visual evaluation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of neural transmission

• Publication date

  2006-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00702-005-0321-5PMID 15959843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology

  2007cited by this paper
• Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

  2005cited by this paper
• PET studies in dementia

  2003cited by this paper
• A critical discussion of the role of neuroimaging in mild cognitive impairment *

  2003cited by this paper
• Statistical Parametric Mapping of Brain SPECT Perfusion Abnormalities in Patients with Alzheimer’s Disease

  2003cited by this paper
• Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.

  2003cited by this paper
• Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia

  2003cited by this paper
• The Clinical Use of 99mTc-HMPAO-SPECT in Alzheimer´s Disease

  2003cited by this paper
• Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.

  2002cited by this paper
• Imaging dementias

  2001cited by this paper
• CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2001cited by this paper
• Brain SPECT in neurology and psychiatry.

  2001cited by this paper
• Of MCI and dementia: Improving diagnosis and treatment

  2001cited by this paper
• Single photon emission CT and positron emission tomography in the evaluation of neurologic disease.

  2001influential reference
• Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease

  2001cited by this paper
• The role of neuroimaging in dementia.

  2001cited by this paper
• Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

  2000cited by this paper
• [Clinical applications of single photon emission tomography in neurology. 2. Dementia, psychoses, inflammation, skull and brain injuries].

  2000cited by this paper
• Activate your online subscription

  2000cited by this paper
• Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?

  2000influential reference
• Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion Spect the Recruitment Was For

  2000cited by this paper
• Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias

  2000cited by this paper
• Neuroimaging in dementia.

  2000cited by this paper
• [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].

  2000cited by this paper
• FDG PET imaging in patients with pathologically verified dementia.

  2000cited by this paper
• Clinical applications of single photon emission tomography in neuromedicine

  2000cited by this paper
• Brain perfusion imaging predicts survival in Alzheimer's disease

  1998influential reference
• Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias

  1998cited by this paper
• Preclinical prediction of Alzheimer's disease using SPECT

  1998cited by this paper
• Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias

  1997cited by this paper
• Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.

  1997cited by this paper
• Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: evaluation of an observer-independent analytic approach.

  1997cited by this paper
• The Diagnostic Value of Magnetic Resonance Imaging and Technetium 99m‐HMPAO Single‐Photon-Emission Computed Tomography for the Diagnosis of Alzheimer Disease in a Community‐Dwelling Elderly Population

  1997cited by this paper
• Positron emission tomography in dementia.

  1997cited by this paper
• Literacy and Performance on the Mini‐Mental State Examination

  1995cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1991cited by this paper
• Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.

  1991cited by this paper
• Clinical Neuromythology VIII Upper and lower motor neuron

  1990cited by this paper
• Critical analysis of the use of computer‐assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type

  1990cited by this paper
• Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.

  1989cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Positron emission tomography in dementia.

  1983cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• WIP, reduzierter Wechsler-Intelligenztest

  1972cited by this paper
• A Standardized Memory Scale for Clinical Use

  1945cited by this paper

• Microvascular Perfusion Imaging in Alzheimer's Disease.

  2024cites this paper
• Propofol improves brain injury induced by chronic cerebral hypoperfusion in rats

  2021cites this paper
• Multimodal and Longitudinal Bioimaging Methods for Characterizing the Progressive Course of Dementia

  2019cites this paper
• Cerebral Venous Sinus Stenosis may Cause Intracranial Arterial Hypoperfusion

  2019cites this paper
• Clock drawing test in mild cognitive impairment: Correlation with cerebral perfusion in single-photon emission computed tomography.

  2019cites this paper
• HMPAO-SPECT can discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.

  2019cites this paper
• Optimized sampling for high resolution multi-pinhole brain SPECT with stationary detectors

  2019cites this paper
• Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in Rats

  2018cites this paper
• The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.

  2017cites this paper
• Combining SPECT and Quantitative EEG Analysis for the Automated Differential Diagnosis of Disorders with Amnestic Symptoms

  2017cites this paper
• Does applying resolution recovery to normal databases confer an advantage over conventional 3D-stereotactic surface projection techniques?

  2017cites this paper
• Effect of resolution recovery using graph plots on regional cerebral blood flow in healthy volunteers

  2017cites this paper
• Evaluation of Resolution Recovery for Each Collimator in Brain Perfusion Image.

  2016cites this paper
• CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly Running title : CSF and CBF in healthy elderly

  2016cites this paper
• Utilidad de la Hemodinámica cerebral, medida mediante Doppler Transcraneal, para predecir la conversión de deterioro cognitivo leve a enfermedad de Alzheimer

  2016influential citation
• Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?

  2015cites this paper
• Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats.

  2015cites this paper
• Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer’s Disease

  2015cites this paper
• Retracted: Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion

  2014cites this paper
• Are Brain SPECT Data and Neuropsychological Disturbances Correlated in Patients With Alzheimer Disease and Vascular Dementia ?

  2014influential citation
• Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion

  2014cites this paper
• Brain activation disturbance for target detection in patients with mild cognitive impairment: an fMRI study.

  2012cites this paper
• CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly

  2012cites this paper
• Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia

  2011cites this paper
• Framingham Cardiovascular Risk Profile Correlates with Impaired Hippocampal and Cortical Vasoreactivity to Hypercapnia

  2011cites this paper
• Perfusion SPECT and FDG-PET

  2011cites this paper
• Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study

  2010cites this paper
• Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline.

  2010cites this paper
• Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer’s type: a semiquantitative and automated evaluation

  2009cites this paper
• Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease

  2009cites this paper
• Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

  2007cites this paper
• Visual Rating and ROI-Based Parametric Analysis of rCBF SPECT in Patients with Mild or Questionable Dementia: A Comparative Study

  2007cites this paper
• A quantitative near-infrared spectroscopy study: a decrease in cerebral hemoglobin oxygenation in Alzheimer's disease and mild cognitive impairment.

  2006cites this paper